Search Results - "Rubinstein, Paul G."

KSHV/HHV8-mediated hematologic diseases by Cesarman, Ethel, Chadburn, Amy, Rubinstein, Paul G.

“…Kaposi sarcoma (KS) herpesvirus (KSHV), also known as human herpesvirus 8, is the causal agent of KS but is also pathogenetically related to several…”
Get full text

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells by Reichel, Jonathan, Chadburn, Amy, Rubinstein, Paul G., Giulino-Roth, Lisa, Tam, Wayne, Liu, Yifang, Gaiolla, Rafael, Eng, Kenneth, Brody, Joshua, Inghirami, Giorgio, Carlo-Stella, Carmelo, Santoro, Armando, Rahal, Daoud, Totonchy, Jennifer, Elemento, Olivier, Cesarman, Ethel, Roshal, Mikhail

“…Classical Hodgkin lymphoma (cHL) is characterized by sparsely distributed Hodgkin and Reed-Sternberg (HRS) cells amid reactive host background, complicating…”
Get full text

Long-term survival in AIDS-related primary central nervous system lymphoma by Gupta, Neel K, Nolan, Amber, Omuro, Antonio, Reid, Erin G, Wang, Chia-Ching, Mannis, Gabriel, Jaglal, Michael, Chavez, Julio C, Rubinstein, Paul G, Griffin, Ann, Abrams, Donald I, Hwang, Jimmy, Kaplan, Lawrence D, Luce, Judith A, Volberding, Paul, Treseler, Patrick A, Rubenstein, James L

“…The optimal therapeutic approach for patients with AIDS-related primary central nervous system lymphoma (AR-PCNSL) remains undefined. While its incidence…”
Get full text

Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma by Mahale, Parag, Nomburg, Jason, Song, Joo Y, Steinberg, Mia, Starrett, Gabriel, Boland, Joseph, Lynch, Charles F, Chadburn, Amy, Rubinstein, Paul G, Hernandez, Brenda Y, Weisenburger, Dennis D, Bullman, Susan, Engels, Eric A

“…Abstract Systemic anaplastic large cell lymphoma (ALCL) is a rare CD30-expressing T-cell non-Hodgkin lymphoma. Risk of systemic ALCL is highly increased among…”
Get full text

Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges by Rubinstein, Paul G, Aboulafia, David M, Zloza, Andrew

“…The incidence of AIDS-defining cancers (ADCs) – Kaposi sarcoma, primary central nervous system lymphoma, non-Hodgkin lymphoma, and cervical cancer – although…”
Get full text

Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV by Rubinstein, Paul G, Galvez, Carlos, Ambinder, Richard F

“…Summarize the latest research of both stem cell transplantation and cellular therapy and present the implications with respect to persons with HIV (PWH),…”
Get full text

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial) by Ramos, Juan C., Sparano, Joseph A., Chadburn, Amy, Reid, Erin G., Ambinder, Richard F., Siegel, Eric R., Moore, Page C., Rubinstein, Paul G., Durand, Christine M., Cesarman, Ethel, Aboulafia, David, Baiocchi, Robert, Ratner, Lee, Kaplan, Lawrence, Capoferri, Adam A., Lee, Jeannette Y., Mitsuyasu, Ronald, Noy, Ariela

“…EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) is a preferred regimen for HIV-non-Hodgkin lymphomas (HIV-NHLs), which are…”
Get full text

Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study by Rajdev, Lakshmi, Jackie Wang, Chia‐Ching, Joshi, Himanshu, Lensing, Shelly, Lee, Jeannette, Ramos, Juan Carlos, Baiocchi, Robert, Ratner, Lee, Rubinstein, Paul G., Ambinder, Richard, Henry, David, Streicher, Howard, Little, Richard F., Chiao, Elizabeth, Dittmer, Dirk P., Einstein, Mark H., Cesarman, Ethel, Mitsuyasu, Ronald, Sparano, Joseph A.

“…Background Although immunotherapy has emerged as a therapeutic strategy for many cancers, there are limited studies establishing the safety and efficacy in…”
Get full text

Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma by Rubinstein, Paul G, Moore, Page C, Rudek, Michelle A, Henry, David H, Ramos, Juan C, Ratner, Lee, Reid, Erin, Sharon, Elad, Noy, Ariela

“…OBJECTIVE:Brentuximab vedotin is a Food and Drug Administration approved anti-CD30 antibody drug conjugate potently active in Hodgkin lymphoma. Trials of…”
Get full text

Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP by Morales, Ayana E, Gumenick, Ruby, Genovese, Caitlyn M, Jang, Yun Yeong, Ouedraogo, Ariene, Ibáñez de Garayo, Maite, Pannellini, Tania, Patel, Sanjay, Bott, Matthew E, Alvarez, Julio, Mun, Sung Soo, Totonchy, Jennifer, Gautam, Archana, Delgado de la Mora, Jesus, Chang, Stephanie, Wirth, Dagmar, Horenstein, Marcelo, Dao, Tao, Scheinberg, David A, Rubinstein, Paul G, Semeere, Aggrey, Martin, Jeffrey, Godfrey, Catherine C, Moser, Carlee B, Matining, Roy M, Campbell, Thomas B, Borok, Margaret Z, Krown, Susan E, Cesarman, Ethel

“…In people living with HIV, Kaposi Sarcoma (KS), a vascular neoplasm caused by KS herpesvirus (KSHV/HHV-8), remains one of the most common malignancies…”
Get full text

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States by Lurain, Kathryn, Zarif, Talal El, Ramaswami, Ramya, Nassar, Amin H., Adib, Elio, Abdel-Wahab, Noha, Chintapally, Nikita, Drolen, Claire E., Feldman, Tatyana, Haykal, Tarek, Nebhan, Caroline A., Thiruvengadam, Swetha Kambhampati, Li, Mingjia, Mittra, Arjun, Lorentsen, Michael, Kim, Chul, Drakaki, Alexandra, Morse, Michael, Johnson, Douglas B., Mangla, Ankit, Dittus, Christopher, Ravi, Praful, Baiocchi, Robert A., Chiao, Elizabeth Y., Rubinstein, Paul G., Yellapragada, Sarvari V., LaCasce, Ann S., Sonpavde, Guru P., Naqash, Abdul Rafeh, Herrera, Alex F.

“…Despite a higher risk of classical Hodgkin lymphoma (cHL) in people with HIV and the demonstrated safety and efficacy of PD-1 blockade in cHL, there are…”
Get full text

Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial by Rubinstein, Paul G, Moore, Page C, Bimali, Milan, Lee, Jeanette Y, Rudek, Michelle A, Chadburn, Amy, Ratner, Lee, Henry, David H, Cesarman, Ethel, DeMarco, Camille E, Costagliola, Dominique, Taoufik, Yassine, Ramos, Juan Carlos, Sharon, Elad, Reid, Erin G, Ambinder, Richard F, Mitsuyasu, Ronald, Mounier, Nicolas, Besson, Caroline, Noy, Ariela, Barta, Stefan K., Hamdan, Ayad, Boué, François, Delobel, Pierre, Galicier, Lionel, Coppo, Paul, Ghesquières, Hervé

“…Brentuximab vedotin in combination with doxorubicin, vinblastine, and dacarbazine (AVD) is approved in the upfront setting for advanced stage classical Hodgkin…”
Get full text

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study by Zayac, Adam S., Landsburg, Daniel J., Hughes, Mitchell E., Bock, Allison M., Nowakowski, Grzegorz S., Ayers, Emily C., Girton, Mark, Hu, Marie, Beckman, Amy K., Li, Shaoying, Medeiros, L. Jeffrey, Chang, Julie E., Stepanovic, Adam, Kurt, Habibe, Sandoval-Sus, Jose, Ansari-Lari, M. Ali, Kothari, Shalin K., Kress, Anna, Xu, Mina L., Torka, Pallawi, Sundaram, Suchitra, Smith, Stephen D., Naresh, Kikkeri N., Karimi, Yasmin H., Epperla, Narendranath, Bond, David A., Farooq, Umar, Saad, Mahak, Evens, Andrew M., Pandya, Karan, Naik, Seema G., Kamdar, Manali, Haverkos, Bradley, Karmali, Reem, Oh, Timothy S., Vose, Julie M., Nutsch, Heather, Rubinstein, Paul G., Chaudhry, Amina, Olszewski, Adam J.

“…•HGBL-NOS is a highly heterogeneous category; PFS (55% at 2 years) did not significantly differ between R-CHOP and intensified regimens.•A dual-expressor (MYC…”
Get full text

Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura: A Case Series by Kowalczyk, Mark, Rubinstein, Paul G., Aboulafia, David M.

“…HIV-associated immune thrombocytopenic purpura (ITP) has decreased in incidence 10-fold since the advent of highly active antiretroviral therapy (HAART). For…”
Get full text

Durable complete remission induced by cetuximab monotherapy in a patient infected with HIV and diagnosed with recurrent squamous cell carcinoma of the head and neck by Rubinstein, Paul G, Lindgren, Valerie, Setty, Suman, Yao, Mike, Pytynia, Kristen B, Radosevich, James A, Kadkol, ShriHari S, Feldman, Lawrence E

Get full text

Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura by Kowalczyk, Mark, Rubinstein, Paul G, Aboulafia, David M

“…HIV-associated immune thrombocytopenic purpura (ITP) has decreased in incidence 10-fold since the advent of highly active antiretroviral therapy (HAART). For…”
Get full text

Delayed hemolysis after intravenous anti‐D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura by Rubinstein, Paul G., Chen, Yi‐Hsiang

Get full text

A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM) by Avila, Ana Maria, Arain, Saad, Sweiss, Karen, Patel, Pritesh, Houshyar, Samin, Calip, Gregory S, Khan, Irum, Rubinstein, Paul G., Uzoka, Chukwuemeka, Quigley, John G.

Get full text

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study by Arain, Saad, Avila, Ana Maria, Christian, Sonia, Patel, Pritesh, Sweiss, Karen, Parkin, Brian, Saraf, Santosh L., Rubinstein, Paul G., Calip, Gregory S, Quigley, John G.

Get full text

Prevalence and outcomes of sepsis in HIV versus non-HIV patients with diffuse large B-cell lymphoma: A nationwide analysis by Tariq, Muhammad Junaid, Baral, Binav, Lingamaneni, Prasanth, Gannamani, Vedavyas, Almani, Muhammad Usman, Gupta, Shweta, Rubinstein, Paul G.

“…Abstract only e19567 Background: With the advent combined anti-retroviral therapy (ART), the survival of people living with HIV has improved, thereby…”
Get full text